Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

QUOTED. Feb. 22, 2018. Dan Vukelich.

Executive Summary

Check out what Association of Medical Device Reprocessors President Dan Vukelich had to say about his expectations in the European market now that new rules of the road are being established for reprocessing of single-use devices in the EU.

“We expect most countries will ultimately opt in to allow commercially available, CE-marked remanufactured single-use devices (SUDs) because such products are now held to the same safety and efficacy standards as all other medical devices.” –Dan Vukelich, president, Association of Medical Device Reprocessors

Click here for a free trial of Medtech Insight

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT122237

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel